Logo-ps
Pharm Sci. 2023;29(1): 52-58. doi: 10.34172/PS.2022.8

Research Article

A Randomized, Single-blind, Comparison Trial of Beractant (BeraksurfTM) versus Poractant Alfa (Curosurf®) in the Treatment of Respiratory Distress Syndrome in Preterm Infants

Manizheh Mostafa Gharehbaghi 1,2, Parvin Sarbakhsh 3, Hossein Mohammadbager 2, Safoora Gharibzadeh 4, Elnaz Shaseb 5,6 * ORCID

Cited by CrossRef: 0


   Indexing & Abstracting:

    

       

 

 

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

 

 

Follower of ICMJE

Powered by: